Ultralife Corporation
ULBI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $123 | $112 | $62 | $97 |
| - Cash | $7 | $10 | $6 | $8 |
| + Debt | $54 | $29 | $24 | $23 |
| Enterprise Value | $171 | $130 | $80 | $112 |
| Revenue | $164 | $159 | $132 | $98 |
| % Growth | 3.7% | 20.3% | 34.2% | – |
| Gross Profit | $42 | $39 | $29 | $25 |
| % Margin | 25.7% | 24.7% | 22.3% | 25.1% |
| EBITDA | $14 | $15 | $5 | $4 |
| % Margin | 8.8% | 9.5% | 3.8% | 3.7% |
| Net Income | $6 | $7 | -$0 | -$0 |
| % Margin | 3.8% | 4.5% | -0.1% | -0.2% |
| EPS Diluted | 0.38 | 0.44 | -0.007 | -0.015 |
| % Growth | -13.6% | 6,045.9% | 49.3% | – |
| Operating Cash Flow | $17 | $2 | -$1 | $4 |
| Capital Expenditures | -$2 | -$3 | -$2 | -$3 |
| Free Cash Flow | $15 | -$1 | -$3 | $2 |